C. Bokemeyer

1.6k total citations
68 papers, 828 citations indexed

About

C. Bokemeyer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, C. Bokemeyer has authored 68 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 22 papers in Surgery. Recurrent topics in C. Bokemeyer's work include Testicular diseases and treatments (16 papers), Neuroblastoma Research and Treatments (8 papers) and Renal cell carcinoma treatment (7 papers). C. Bokemeyer is often cited by papers focused on Testicular diseases and treatments (16 papers), Neuroblastoma Research and Treatments (8 papers) and Renal cell carcinoma treatment (7 papers). C. Bokemeyer collaborates with scholars based in Germany, United Kingdom and France. C. Bokemeyer's co-authors include Hans‐Joachim Schmoll, Lothar Kanz, J.T. Hartmann, A. Gerl, J. Beyer, P. Koralewski, J. T. Hartmann, L. M. Fels, Hilmar Stolte and Igor Bondarenko and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

C. Bokemeyer

67 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bokemeyer Germany 16 299 268 258 171 121 68 828
Herbert Stöger Austria 19 259 0.9× 562 2.1× 198 0.8× 165 1.0× 156 1.3× 68 1.1k
Hideo Takamatsu Japan 18 382 1.3× 246 0.9× 603 2.3× 218 1.3× 81 0.7× 74 1.1k
Emanuele Naglieri Italy 15 200 0.7× 336 1.3× 245 0.9× 210 1.2× 77 0.6× 42 1.0k
Calogero Cipolla Italy 18 209 0.7× 242 0.9× 526 2.0× 113 0.7× 201 1.7× 90 1.0k
W W ten Bokkel Huinink Netherlands 11 163 0.5× 408 1.5× 604 2.3× 182 1.1× 176 1.5× 20 1.2k
Garry Forgeson New Zealand 14 229 0.8× 494 1.8× 175 0.7× 196 1.1× 174 1.4× 22 918
Haluk Onat Türkiye 11 314 1.1× 428 1.6× 753 2.9× 121 0.7× 84 0.7× 31 1.2k
Sandra J. Casak United States 18 215 0.7× 455 1.7× 189 0.7× 171 1.0× 148 1.2× 32 1.0k
M. Henar Alonso United States 19 220 0.7× 361 1.3× 397 1.5× 179 1.0× 140 1.2× 42 1.0k
Daisy Saw China 18 151 0.5× 479 1.8× 279 1.1× 208 1.2× 203 1.7× 37 1.0k

Countries citing papers authored by C. Bokemeyer

Since Specialization
Citations

This map shows the geographic impact of C. Bokemeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bokemeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bokemeyer more than expected).

Fields of papers citing papers by C. Bokemeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bokemeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bokemeyer. The network helps show where C. Bokemeyer may publish in the future.

Co-authorship network of co-authors of C. Bokemeyer

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bokemeyer. A scholar is included among the top collaborators of C. Bokemeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bokemeyer. C. Bokemeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seidel, Christoph, Elizabeth A. Connolly, Peter Grimison, et al.. (2024). Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis. ESMO Open. 9(5). 103449–103449. 2 indexed citations
2.
Holstein, Katharina, et al.. (2017). Der Einfluss angeborener Blutungsneigungen auf den sozioökonomischen Status erwachsener Patient – Ergebnisse einer vergleichenden Single-Centre-Kohortenstudie. Hämostaseologie. 2 indexed citations
3.
Holstein, Katharina, Reinhard Schneppenheim, Johanna Schrum, C. Bokemeyer, & Florian Länger. (2014). Erfolgreiche zweite Immuntoleranzinduktion mit Faktor IX und kombinierter Immunsuppression bei einem Patienten mit schwerer Hämophilie B und Inhibitor-Rezidiv. Hämostaseologie. 34. 1 indexed citations
4.
Schneppenheim, Reinhard, Johanna Schrum, C. Bokemeyer, Florian Länger, & Katharina Holstein. (2014). Successful second ITI with factor IX and combined immunosuppressive therapy. Hämostaseologie. 34(S 01). S5–S8. 5 indexed citations
5.
Köllermann, Jens, Thorsten Schlomm, Hartwig Huland, et al.. (2010). Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients. Oncology Letters. 1(4). 729–732. 13 indexed citations
6.
Kuczyk, M., Gerd Wegener, Axel S. Merseburger, et al.. (2005). Impact of tumor size on the long-term survival of patients with early stage renal cell cancer. World Journal of Urology. 23(1). 50–54. 9 indexed citations
7.
Oechsle, Karin, C. Kollmannsberger, B. Dohmen, et al.. (2004). [18F]FDG-PET, CT/MRT und Tumormarker als prädiktive Indikatoren für das Ansprechen unter Hochdosis-Chemotherapie bei Patienten mit metastasierten Keimzelltumoren. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 176(1). 76–84. 9 indexed citations
8.
Merseburger, Axel S., Gerd Wegener, Marcus Horstmann, et al.. (2003). Welche Tumorgröße korreliert am besten mit dem Progressionsrisiko lokal organbegrenzter Nierenzellkarzinome?. Aktuelle Urologie. 34(7). 469–474. 1 indexed citations
9.
Honecker, Friedemann, Gerald Kolb, & C. Bokemeyer. (2002). Therapie alterer Patienten mit kolorektalem Karzinom. Wiener Medizinische Wochenschrift. 152(7-8). 170–176. 1 indexed citations
10.
Hartmann, J. T., S.D. Fosså, Craig R. Nichols, et al.. (2001). Incidence of Metachronous Testicular Cancer in Patients With Extragonadal Germ Cell Tumors. JNCI Journal of the National Cancer Institute. 93(22). 1733–1738. 121 indexed citations
11.
Hebart, Holger, C. Bokemeyer, Jürgen Löffler, et al.. (1997). New Aspects for the Diagnosis of Invasive Fungal Disease in Oncological Patients. Oncology Research and Treatment. 20(2). 99–104. 2 indexed citations
12.
Kuczyk, M.A., C. Bokemeyer, Geoffrey P. Kohn, et al.. (1997). Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancer. British Journal of Urology. 80(1). 18–24. 32 indexed citations
13.
14.
Kuczyk, M., et al.. (1996). [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].. PubMed. 35(1). 35–45. 1 indexed citations
15.
Bokemeyer, C., et al.. (1995). No synergistic activity of epirubicin and interferon-?2b in the treatment of hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 35(4). 334–338. 1 indexed citations
16.
Wagner, Siegfried, et al.. (1994). Interaction between <i>Helicobacter pylori and </i>Human Gastric Epithelial Cells in Culture: Effect of Antiulcer Drugs. Pharmacology. 49(4). 226–237. 31 indexed citations
17.
Bokemeyer, C., Hans‐Joachim Schmoll, A. Harstrick, et al.. (1993). A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours. European Journal of Cancer. 29(16). 2225–2231. 21 indexed citations
18.
Bokemeyer, C., et al.. (1993). Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors. Journal of Cancer Research and Clinical Oncology. 119(11). 685–688. 3 indexed citations
19.
Bokemeyer, C., Beryn Frank, Almuth Brandis, & Wolfgang Weinrich. (1990). Giant aneurysm causing frontal lobe syndrome. Journal of Neurology. 237(1). 47–50. 14 indexed citations
20.
Harstrick, A., Hans‐Joachim Schmoll, Hans‐Joachim Wilke, et al.. (1990). High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study. Annals of Oncology. 1(5). 375–376. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herbert Stöger Breakdown of academic impact, for papers by Hideo Takamatsu Breakdown of academic impact, for papers by Emanuele Naglieri Breakdown of academic impact, for papers by Calogero Cipolla Breakdown of academic impact, for papers by W W ten Bokkel Huinink Breakdown of academic impact, for papers by Garry Forgeson Breakdown of academic impact, for papers by Haluk Onat Breakdown of academic impact, for papers by Sandra J. Casak Breakdown of academic impact, for papers by M. Henar Alonso Breakdown of academic impact, for papers by Daisy Saw
Rankless by CCL
2026